Cargando…
Treatment of non-small-cell lung cancer: a perspective on the recent advances and the experience with gefitinib
Worldwide, non-small-cell lung cancer (NSCLC) is a leading cause of cancer-related mortality and, until screening detects early disease, treatment for the majority of patients will consist of radiation therapy, chemotherapy or combinations thereof. Modern mono and doublet chemotherapy regimens have...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2004
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750809/ https://www.ncbi.nlm.nih.gov/pubmed/15340373 http://dx.doi.org/10.1038/sj.bjc.6602062 |